Delivery Order SPE2DB24D1104-SPE2DB25FYAD8
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $18,401.39 by the Defense Logistics Agency (DLA) on August 8, 2025. The contract, designated as 4569035711, covers the supply of PREVNAR 20 vaccine in 0.5 milliliter syringes, with an ultimate completion date of August 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Prevnar 20 Syringe 0.5ML vaccines. This competitively awarded, firm fixed-price delivery order has a ceiling value of $73,941.30 and an ultimate completion date of July 23, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $18,442.87 by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Prevnar 20 vaccine in 0.5ML syringes. The contract is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a non-competed award. Performance of this contract will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,802.62 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Prevnar 20 Syringe 0.5ML, a pneumococcal vaccine. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract against AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,989.90 by the Defense Logistics Agency (DLA) on July 14, 2025. The order is for Prevnar 20 vaccine in 0.5ml syringes and will be completed by July 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 21, 2025, for the supply of Prevnar 20 syringes (0.5ML) valued at $45,250.20. This firm fixed-price contract, with an ultimate completion date of August 22, 2025, represents a non-competitive, competitively awarded order under the Defense Logistics Agency's Medical Supply Chain. The award supports federal medical procurement needs, particularly for...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $32,675.40 by the Defense Logistics Agency on August 15, 2025, for the supply of Prevnar 20 vaccine in 0.5 mL syringe format. This is a firm fixed-price contract with an ultimate completion date of August 18, 2025, with no set-aside designation applied. The award represents a competitively-bid delivery order executed under the company's existing contract vehicle with DLA, reflecting the agency's continued reliance on...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Prevnar 20 vaccine in 0.5mL syringes. The contract, valued at $98,026.20 with a firm fixed price structure, is scheduled for completion by August 11, 2025, and will be performed at the company's corporate office location in Conshohocken, PA 19428. This is a competitively awarded,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 8, 2025, valued at $21,820.23 for the supply of PREVNAR 20 vaccine in 0.5 mL syringes. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of May 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a relatively small transaction within...
- AmerisourceBergen Drug Corp was awarded a $5,560.53 delivery order by the Defense Logistics Agency for Prevnar 20 vaccine in syringe form (0.5mL), with an ultimate completion date of August 27, 2025. The contract was awarded on August 26, 2025, using firm fixed price terms with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and a primary distribution center for its pharmaceutical supply...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYAD8Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on April 22, 2025, for the supply of Prevnar 20 vaccine in 0.5 milliliter syringes. This firm fixed-price delivery order, valued at $10,289.11, is scheduled for completion by April 23, 2025, and represents a non-set-aside, competitively awarded contract. The award was executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. AmerisourceBergen Drug Corp maintains a significant role as a critical federal medical procurement vendor, particularly for the Defense Logistics Agency and Defense Health Agency. The company's extensive federal contracting portfolio demonstrates its capacity to fulfill diverse pharmaceutical and medical supply requirements for military and veteran healthcare systems. This delivery order for Prevnar 20 vaccine aligns with the company's established operational footprint and proven capability to deliver vaccines and specialized medical commodities through firm fixed-price arrangements with accelerated completion timelines.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 4/22/25 |